Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Articles|July 13, 2021

WCG Acquires Intrinsic Imaging

WCG has announced the acquisition of Intrinsic Imaging, a global provider of medical imaging core lab services. With over a decade of experience, a team of more than 500 board-certified physicians and comprehensive services in support of drug, medical device and artificial intelligence clinical trials, Intrinsic Imaging supports WCG’s scientific and regulatory capabilities, complementing the Company’s suite of solutions.

Moving forward, Intrinsic Imaging will be known as WCG Intrinsic Imaging. The organization will retain its leadership structure and continue to operate from its Bolton, Massachusetts headquarters.


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.